Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Omodysplasia is a rare skeletal dysplasia characterized by severe limb shortening and facial dysmorphism. Two types of omodysplasia have been described: an autosomal recessive or generalized form (also referred to as micromelic dysplasia with dislocation of radius) marked by severe micromelic dwarfism with predominantly rhizomelic shortening of both the upper and lower limbs, and an autosomal dominant form in which stature is normal and shortening is limited to the upper limbs.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for omodysplasia.
3 publications have been identified in PubMed for omodysplasia. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Jurk S (2026). [PMID: 41022130](https://pubmed.ncbi.nlm.nih.gov/41022130/). *Z Geburtshilfe Neonatol*. [Case Report / Case Series]
Das S (2024). [PMID: 39262525](https://pubmed.ncbi.nlm.nih.gov/39262525/). *Cureus*. [Case Report / Case Series]
Ouidja MO (2024). [PMID: 39630030](https://pubmed.ncbi.nlm.nih.gov/39630030/). *Essays Biochem*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 6:27 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center